PMID: 3757767Jul 1, 1986Paper

Contingent methadone delivery: effects on illicit-opiate use

Drug and Alcohol Dependence
S T HigginsI Liebson

Abstract

This study examined the effects of contingent vs. non-contingent delivery of a methadone dose supplement on relapse to illicit opiate use in the context of a methadone outpatient detoxification program. Following a 3-week methadone stabilization period on 30 mg, patients (N = 39) were randomly assigned to a contingent, a non-contingent, or a control treatment group. All patients received identical gradual reductions in their assigned methadone dose. During the dose reduction period (weeks 4-11), members of the contingent (N = 13) and non-contingent groups (N = 13) could obtain daily methadone-dose supplements up to 20 mg, but contingent group members could obtain supplements only if their most recent urinalysis results were opiate negative. Control subjects (N = 13) did not have dose increases available. The contingent group presented significantly lower opiate-positive urines during weeks 8-11 (14% positive) of the detox than the non-contingent (38% positive) or control (50% positive) groups. Additionally, the availability of extra methadone improved treatment retention and increased clinic attendance above levels observed in the control group. The potential for further use of methadone's reinforcing properties in the treatmen...Continue Reading

References

May 28, 1976·Psychopharmacologia·T E WernerW M Davis
Sep 1, 1984·Drug and Alcohol Dependence·M L StitzerI A Liebson

❮ Previous
Next ❯

Citations

Jan 1, 1987·Journal of Substance Abuse Treatment·D A Calsyn, A J Saxon
Jan 1, 1990·Journal of Substance Abuse Treatment·D Nolimal, T J Crowley
Jan 5, 2002·Drug and Alcohol Dependence·Elias RoblesKenneth Silverman
Jun 14, 2002·Drug and Alcohol Dependence·Michael L PrendergastDarren Urada
Jul 4, 2002·Drug and Alcohol Dependence·Kenzie L PrestonDavid H Epstein
Dec 11, 1996·Drug and Alcohol Dependence·D A CalsynV V Stanton
Feb 11, 2000·Drug and Alcohol Dependence·J D GriffithD D Simpson
Mar 10, 2001·Journal of Substance Abuse Treatment·N M PetryB Martin
Jan 1, 1988·Journal of Substance Abuse·W K BickelW F Knight
Apr 26, 2000·Journal of Consulting and Clinical Psychology·N M PetryH R Kranzler
Sep 12, 2001·Journal of Consulting and Clinical Psychology·K L PrestonD H Epstein
Feb 29, 2008·Journal of Psychoactive Drugs·Sandra M GallagherWendy Layne
Nov 1, 1990·British Journal of Addiction·J WolkJ M Simpson
Oct 11, 2001·The Australian & New Zealand Journal of Obstetrics & Gynaecology·G K Hulse, G O'Neill
Aug 25, 2007·Annual Review of Clinical Psychology·Maxine Stitzer, Nancy Petry
Jun 24, 2008·Science & Practice Perspectives·Robert K Brooner, Michael Kidorf
May 28, 2013·Addictive Behaviors·John M RollSterling McPherson
Jan 4, 2012·The American Journal on Addictions·Leonardo F AndradeNancy M Petry
May 8, 2010·Drug and Alcohol Review·Hans O Melberg, Keith Humphreys
Mar 29, 2001·Annual Review of Public Health·J L Sindelar, D A Fiellin
Jan 13, 2009·Substance Use & Misuse·George W JoeGrace A Rowan-Szal
Aug 30, 2018·Clinical Trials : Journal of the Society for Clinical Trials·Ekaterina BurduliSterling M McPherson
Jun 24, 2010·Journal of Clinical Psychopharmacology·Johannes StrasserKenneth M Dürsteler-Macfarland
Sep 9, 2011·The Cochrane Database of Systematic Reviews·Laura AmatoSimona Vecchi
Jul 1, 1995·The International Journal of the Addictions·J G BakerC A Carson
Apr 1, 1994·The International Journal of the Addictions·W DeJong
Jul 8, 1999·The American Journal of Drug and Alcohol Abuse·D T HartzS M Hall
Jan 1, 1991·Journal of Applied Behavior Analysis·A J BudneyW K Bickel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.